Axial Biotech, a provider of molecular diagnostic assays and other technologies, has appointed William Lister to its board of directors.
Subscribe to our email newsletter
Mr Lister will serve on the board’s compensation committee and will focus on guiding the company in the commercialization of new molecular assays.
Most recently, Mr Lister was the senior vice president and general manager of patient care at Roche Diagnostics. Mr Lister has received a bachelor of science degree in management and a master of science degree in marketing from Indiana State University.
John Climaco, president and CEO of Axial Biotech, said: “Bill has a very impressive record in the diagnostics industry of creating and executing major strategies as well as helping companies build the foundation for meaningful and sustained growth. His skills will be instrumental in helping the company achieve its new expansion imperatives.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.